EMERALD ADVISERS, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001015083

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidDiversifiedHigh Turnover how tags are computed

Q2 2026 · 237 positions · Total reported value $4.25B · Top-10 concentration 17.4% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 51.0% · 14 new · 86 cut · 28 exited

Active Share (vs S&P 500): 97.9% · vs QQQ: 98.3% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -14.5% · vs SPY -16.6% · Prev Value $4.25B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.4% · vs SPY -6.6% · Latest Value $3.63B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2026 13F filing, EMERALD ADVISERS, LLC disclosed 237 equity positions with a combined reported value of $4.25B. The filing implies a diversified portfolio: its ten largest positions account for 17.4% of reported value. HoldingsHub classifies the profile as Mid / Diversified / High Turnover.

The largest disclosed positions as of Q2 2026 were TVTX ($90.95M), CDNL ($79.88M), MRCY ($78.13M). By sector, the heaviest allocations are Technology 26.5%, Health Care 21.7%. Versus the prior quarter, allocation shifted toward Technology (+3.0pp), Industrials (+2.3pp) and away from Financials (-1.4pp), Other (-2.0pp).

Versus the prior quarter, EMERALD ADVISERS, LLC opened 14 new positions, trimmed 86 and fully exited 28, a turnover rate of 51.0% of positions. The portfolio's overlap with the prior quarter was 76% of names.

The largest new positions opened in Q2 2026 were LGN ($55.72M), SXT ($48.69M), TEX ($39.46M).

Of the 28 positions fully exited versus the prior quarter, the largest were BBIO ($38.27M), SPXC ($29.44M), KALV ($25.44M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • LGN LEGENCE CORP · $55.72M
  • SXT SENSIENT TECHNOLOGIES CORP · $48.69M
  • TEX TEREX CORP NEW · $39.46M
  • HRI HERC HLDGS INC · $37.43M
  • MXL MAXLINEAR INC · $35.89M
  • MTRN MATERION CORP · $27.60M
  • NPKI NPK INTERNATIONAL INC · $25.04M
  • DNTH DIANTHUS THERAPEUTICS INC · $24.16M

Fully Exited (vs previous quarter)

  • BBIO BRIDGEBIO PHARMA INC · prev qtr: $38.27M
  • SPXC SPX TECHNOLOGIES INC · prev qtr: $29.44M
  • KALV KALVISTA PHARMACEUTICALS INC · prev qtr: $25.44M
  • SITM SITIME CORP · prev qtr: $22.71M
  • IONQ IONQ INC · prev qtr: $12.91M
  • SLNO SOLENO THERAPEUTICS INC · prev qtr: $9.18M
  • SKYT SKYWATER TECHNOLOGY INC · prev qtr: $7.86M
  • BYRN BYRNA TECHNOLOGIES INC · prev qtr: $3.97M

Insider Transactions (Form 4)

Latest EMERALD ADVISERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Emerald Advisers is an SEC-registered 13F filer based in Leola, PA, United States. As of Q2 2026 it reported 237 US equity positions with a combined value of $4.25B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: LEOLA, PA, United States
  • SEC registration: 801-40263 (status: Approved), registered 1991-11-25
  • Regulatory AUM (Form ADV): $3.30B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Website: teamemerald.com

Portfolio Structure

  • 237 positions · $4.25B reported value (Q2 2026)
  • Top 10 holdings = 17.4% of reported value
  • Largest position: TVTX (TRAVERE THERAPEUTICS INC) at 2.1%
  • Average position size: $17.93M

Sector Tilt

  • Information Technology 26.5%
  • Health Care 21.7%
  • Consumer Discretionary 19.5%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 28 new, 76 added, 81 reduced, 39 exited
  • 52 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Technology 26.5%
Health Care 21.7%
Industrials 15.9%
Financials 9.7%
Other 3.6%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 1.60M $90.95M 2.14%
2.14%
Add
2 847.97K $79.88M 1.88%
1.88%
Add
3 638.68K $78.13M 1.84%
1.84%
Add
4 521.92K $74.60M 1.76%
1.76%
Add
5 323.15K $73.84M 1.74%
1.74%
Add
6 551.53K $73.77M 1.74%
1.74%
Reduce
7 89.30K $71.31M 1.68%
1.68%
Reduce
8 736.78K $66.86M 1.57%
1.57%
Add
9 748.33K $65.07M 1.53%
1.53%
Add
10 787.10K $64.72M 1.52%
1.52%
Add
11 393.03K $63.61M 1.50%
1.50%
Reduce
12 223.52K $63.28M 1.49%
1.49%
Add
13 179.80K $62.94M 1.48%
1.48%
Add
14 330.47K $62.61M 1.47%
1.47%
Add
15 884.29K $62.60M 1.47%
1.47%
Add
16 207.71K $62.45M 1.47%
1.47%
Add
17 843.63K $62.35M 1.47%
1.47%
Add
18 1.60M $62.05M 1.46%
1.46%
Add
19 475.11K $55.87M 1.31%
1.31%
Add
20 653.79K $55.72M 1.31%
1.31%
New
21 468.30K $54.82M 1.29%
1.29%
Add
22 364.02K $54.61M 1.28%
1.28%
Reduce
23 202.75K $54.14M 1.27%
1.27%
Reduce
24 536.16K $52.22M 1.23%
1.23%
Add
25 640.62K $51.54M 1.21%
1.21%
Add
26 736.85K $51.30M 1.21%
1.21%
Reduce
27 567.43K $50.38M 1.19%
1.19%
Reduce
28 345.69K $49.35M 1.16%
1.16%
Add
29 300.23K $49.32M 1.16%
1.16%
Add
30 1.64M $48.76M 1.15%
1.15%
Add
31 394.93K $48.69M 1.15%
1.15%
New
32 375.86K $45.10M 1.06%
1.06%
Add
33 427.85K $44.71M 1.05%
1.05%
Add
34 513.98K $41.77M 0.98%
0.98%
Add
35 221.63K $41.45M 0.98%
0.98%
Reduce
36 3.30M $40.65M 0.96%
0.96%
Add
37 673.73K $39.83M 0.94%
0.94%
Add
38 971.49K $39.68M 0.93%
0.93%
Add
39 2.19M $39.51M 0.93%
0.93%
Add
40 545.05K $39.46M 0.93%
0.93%
New
41 457.96K $39.01M 0.92%
0.92%
Add
42 326.70K $38.33M 0.90%
0.90%
Add
43 2.01M $38.15M 0.90%
0.90%
Add
44 345.47K $37.81M 0.89%
0.89%
Add
45 261.15K $37.43M 0.88%
0.88%
New
46 298.55K $37.09M 0.87%
0.87%
Reduce
47 280.35K $35.89M 0.84%
0.84%
New
48 288.37K $35.45M 0.83%
0.83%
Add
49 841.19K $35.30M 0.83%
0.83%
Reduce
50 229.49K $35.07M 0.82%
0.82%
Add

FAQ

What did EMERALD ADVISERS, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, EMERALD ADVISERS, LLC reported 237 equity positions worth $4.25B in aggregate; its largest disclosed positions were TVTX ($90.95M), CDNL ($79.88M), MRCY ($78.13M).

How large is EMERALD ADVISERS, LLC's portfolio?

EMERALD ADVISERS, LLC reported $4.25B of long equity holdings across 237 positions as of 2026-Q2. Top-10 holdings account for 17.4% of reported value.

What is EMERALD ADVISERS, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Diversified / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/emerald-advisers/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →